TG Therapeutics
TGTX
TGTX
115 hedge funds and large institutions have $200M invested in TG Therapeutics in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 43 increasing their positions, 27 reducing their positions, and 27 closing their positions.
Holders
115
Holders Change
-12
Holders Change %
-9.45%
% of All Funds
2.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
43
Reduced
27
Closed
27
Calls
$4.51M
Puts
$2.2M
Net Calls
+$2.3M
Net Calls Change
+$4.13M
Top Buyers
| 1 |
BM
1
Bridger Management
New York
|
$15.5M |
| 2 |
GPP
2
Great Point Partners
Greenwich,
Connecticut
|
$12.3M |
| 3 |
3
Two Sigma Investments
New York
|
$3.15M |
| 4 |
ACA
4
Avoro Capital Advisors
New York
|
$19.5M |
| 5 |
5
Renaissance Technologies
New York
|
$3.59M |
